Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check40 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check55 days agoChange DetectedThe website has posted new results (v2.14.1) on January 16, 2025, following the deletion of the previous results (v2.14.0) submitted on August 1, 2023.SummaryDifference2%
- Check62 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check91 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.